Yair Einhorn
@yaireinhorn
Science & Innovation. Special interest in BioTech, Pharma, Gene Editing & CRISPR 🧬. Also sharing my thoughts on the Financial Markets & the Global Economy. 📈
ID: 1238780417324580867
14-03-2020 10:54:12
18,18K Tweet
13,13K Takipçi
46 Takip Edilen
An important milestone in #ocular #GeneEditing was Beam Therapeutics’s recent #ASGCT2023 presentation of its preclinical data regarding the first ever use made with In Vivo #BaseEditing #technology aimed to correct a #gene #mutation which causes #Stargardt - an inherited retinal diseases